James Blome Sells 2,582 Shares of Calyxt Inc (CLXT) Stock

Calyxt Inc (NASDAQ:CLXT) CEO James Blome sold 2,582 shares of the stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.65, for a total value of $42,990.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

James Blome also recently made the following trade(s):

  • On Tuesday, March 26th, James Blome sold 2,582 shares of Calyxt stock. The shares were sold at an average price of $17.87, for a total value of $46,140.34.
  • On Tuesday, March 19th, James Blome sold 2,582 shares of Calyxt stock. The shares were sold at an average price of $17.32, for a total value of $44,720.24.
  • On Tuesday, March 12th, James Blome sold 2,582 shares of Calyxt stock. The shares were sold at an average price of $16.58, for a total value of $42,809.56.

NASDAQ CLXT opened at $16.64 on Friday. The firm has a market cap of $544.08 million, a PE ratio of -18.29 and a beta of 2.79. The company has a debt-to-equity ratio of 0.20, a current ratio of 13.64 and a quick ratio of 13.64. Calyxt Inc has a twelve month low of $8.83 and a twelve month high of $22.32.

Calyxt (NASDAQ:CLXT) last released its quarterly earnings results on Monday, March 11th. The company reported ($0.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.01). Calyxt had a negative return on equity of 31.55% and a negative net margin of 11,820.76%. As a group, equities analysts expect that Calyxt Inc will post -1.29 earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Northern Trust Corp lifted its position in shares of Calyxt by 12.1% during the second quarter. Northern Trust Corp now owns 63,779 shares of the company’s stock worth $1,191,000 after purchasing an additional 6,903 shares during the last quarter. BlackRock Inc. lifted its position in shares of Calyxt by 4.0% during the third quarter. BlackRock Inc. now owns 762,532 shares of the company’s stock worth $11,643,000 after purchasing an additional 28,978 shares during the last quarter. FMR LLC lifted its position in shares of Calyxt by 1.1% during the third quarter. FMR LLC now owns 4,851,953 shares of the company’s stock worth $74,089,000 after purchasing an additional 52,654 shares during the last quarter. Blair William & Co. IL lifted its position in shares of Calyxt by 8.8% during the third quarter. Blair William & Co. IL now owns 52,681 shares of the company’s stock worth $804,000 after purchasing an additional 4,280 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its position in shares of Calyxt by 50.0% during the third quarter. Point72 Asset Management L.P. now owns 449,898 shares of the company’s stock worth $6,870,000 after purchasing an additional 149,898 shares during the last quarter. 26.97% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts have issued reports on CLXT shares. National Securities started coverage on Calyxt in a report on Wednesday, March 6th. They issued a “buy” rating and a $35.00 target price for the company. Zacks Investment Research upgraded Calyxt from a “hold” rating to a “buy” rating and set a $13.00 price target for the company in a report on Tuesday, January 15th. Finally, Citigroup increased their price target on Calyxt from $13.00 to $16.00 and gave the stock a “neutral” rating in a report on Wednesday, February 27th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $21.80.

TRADEMARK VIOLATION NOTICE: “James Blome Sells 2,582 Shares of Calyxt Inc (CLXT) Stock” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2019/04/27/insider-selling-calyxt-inc-clxt-ceo-sells-2582-shares-of-stock.html.

Calyxt Company Profile

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.

Featured Story: When is a capital gain realized?

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.